Abcam (ABCZF) Interest Expense : $-10.7 Mil (TTM As of Jun. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Abcam Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Abcam's interest expense for the six months ended in Jun. 2023 was $ -6.6 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was $-10.7 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Abcam's Operating Income for the six months ended in Jun. 2023 was $ 35.2 Mil. Abcam's Interest Expense for the six months ended in Jun. 2023 was $ -6.6 Mil. Abcam's Interest Coverage for the quarter that ended in Jun. 2023 was 5.37. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Abcam Interest Expense Historical Data

The historical data trend for Abcam's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abcam Interest Expense Chart

Abcam Annual Data

Trend

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Dec22

Interest Expense

Get a 7-Day Free Trial

-4.35

-0.38

-3.50

-6.58

Abcam Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Jun22	Dec22	Jun23
Interest Expense	Get a 7-Day Free Trial															-2.55	-1.82	-2.46	-4.14	-6.57

Abcam Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-10.7 Mil.

Abcam (OTCPK:ABCZF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Abcam's Interest Expense for the six months ended in Jun. 2023 was $-6.6 Mil. Its Operating Income for the six months ended in Jun. 2023 was $35.2 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2023 was $113.0 Mil.

Abcam's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Jun. 2023 )	/	Interest Expense (Q: Jun. 2023 )
	=	-1	*	35.227	/	-6.566
	=	5.37

The higher the ratio, the stronger the company's financial strength is.

Abcam (ABCZF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abcam PLC (OTCPK:ABCZF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Discovery Drive, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AX

Website

https://www.abcam.com

Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.